Phase II Study Of The Tolerability And Efficacy Of The Histone Deacetylase Inhibitor Sodium Valproate Given In Conjunction With ATRA (All Tans Retinoic Acid) In Patients With Acute Myeloid Leukaemia

Project Details

Short titlePhase II Study Of The Tolerability And Efficacy Of The Histone Deacetylase Inhibitor Sodium Valproate Given In Conjunction With ATRA (All Tans Retinoic Acid) In Patients With Acute Myeloid Leukaemia
StatusFinished
Effective start/end date1/01/04 → 28/02/11

Funding

  • BLOODWISE
  • PHARMION CORPORATION
  • ROCHE PRODUCTS LIMITED
View all
View less